Featured Posts
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
Search Posts
Heartlander
Critical Drug Shortages Reaching Crisis
From Ashley Bateman's article on Heartland.org: But according to Greg Conko, a senior fellow at the Competitive Enterprise Institute, more mandates on companies…
Medical Progress Today
Mayo v. Prometheus and Diagnostic Patents: What Does the Supreme Court Decision Really Mean?
I finally had a chance to read the Supreme Court's recent decision in the Mayo v. Prometheus Labs case, which invalided two patents claiming methods…
Medical Progress Today
The Orphan Drug Conundrum
It’s not a crisis. Yet. Bigger health care issues loom. Right now. There are still fortunes to be made. While it lasts. But one could…
Medical Progress Today
Seeking Solution to “Incredibly Complex” Issue of Drug Shortages
Medical Progress Today
The FDA vs. Commercial Speech
The ability of physicians to prescribe approved medicines for purposes not sanctioned by the Food and Drug Administration (FDA) is one of the most important…
Medical Progress Today
The 510(k) Program Should Be Saved, Not Scorned
Medical Progress Today
Economics at Heart of Drug Shortages
Medical Progress Today
Competitive Enterprise Institute Pleased With PDUFA Recommendations
Medical Progress Today
Think Tank: More FDA 510(k) Oversight Needed, Driving Innovation Overseas
Medical Progress Today
Competitive Enterprise Institute Criticizes the FDA
Medical Progress Today
Conservative think tank report blasts FDA
Medical Progress Today
News Bites: Bachmann’s IPAB Claims Fall Flat
News Release
New Study Reveals Mismanagement of FDA Medical Device Reviews
Washington, D.C., October 12, 2011—The Food and Drug Administration’s 510(k) review process for medical devices has been severely mismanaged by agency officials, according to…
Study
Stifling Medical Device Innovation
The United States has long been the home to cutting-edge innovations in the medical device industry. However, increasingly burdensome regulatory policy is driving pioneering research…
Medical Progress Today
How To Create Shortages In An Abundant World
An old cold war joke asks a Russian, a Pole, an Israeli, and an American the following man-on-the-street question. “Excuse me, what is your opinion…
Breitbart
Breathless: FDA Bans Asthma Medication
Remember when Barack Obama – with the dignity and off-prompter grace, evincing deep understanding of the issues and the eloquence for which he is fawned…
Washington Times
Questionable Motives Behind Supplement Bill
Washington Times
Medical Magellans
Food and Drug Administration (FDA) rules are supposedly intended to ensure the safety and efficacy of new drugs and medical devices. It is FDA’s technology…
Products
Gregory Conko Discussing Cloning Translating Into Big Business and Safety Issues on CNNfn
CNNfn: Money & Markets (c) 2003 Federal Document Clearing House. All Rights Reserved. Friday, October 31, 2003 Business Cloning Translating Into Big Business and Safety…
Study
Safety, risk and the precautionary principle: rethinking precautionary approaches to the regulation of transgenic plants
Full Document Available in PDF Ever since completion of the Cartagena Protocol on Biosafety in…
Legal Brief
Memorandum Opinion in Association of Physicians and Surgeons vs US FDA
Comment
Comments Regarding the Constitutionality of FDA Treatment of Product Information
This request for comments represents a welcome departure from FDA’s prior treatment of First Amendment concerns in the context of product advertising, labeling, and promotions.
Study
Hidden Truth: The Perils and Protection of Off-Label Drug and Medical Device Promotion
Full Document Available in PDF What can you do if you learn you have a life-threatening…
News Release
CEI Slams FDA Vote on Avastin
Washington, D.C., June 29, 2011 — An FDA advisory committee voted today to revoke the approval for breast cancer treatment from the drug Avastin.
Washington Times
Greg Conko on FDA Approval for Avastin
CEI Senior Fellow Greg Conko discusses the FDA's pending decision on whether or not to withdraw its approval of Avastin as a treatment for breast…
Washington Times
There’s No ‘Average’ Cancer Patient
On June 28, the Food and Drug Administration (FDA) will hold a hearing to decide the fate of Avastin, a drug taken by thousands…
Washington Times
Obama’s Generic Proposal Is No Prescription for Health Savings
President Obama has been taking shots at the pharmaceutical industry since announcing his deficit reduction plan in a speech last Wednesday (April 13). Despite relying…
Study
Reject the Precautionary Principle, a Threat to Technological Progress
Liberate to Stimulate Index Increasingly, governments and environmental activists are demanding that producers of both new and old technologies prove that their…
Study
Reduce Burdensome Regulation of Medicines and Medical Devices
Liberate to Stimulate Index Over the past century, American consumers have benefited from thousands of new pharmaceuticals and medical devices to help…
Study
Improve Food Safety and Quality through Greater Information, Consumer Choice, and Legal Accountability
Liberate to Stimulate Index Few issues are as important to consumers as the safety and quality of their food—from microbial contaminants to…
Study
Protect Incentives for Pharmaceutical Innovation
Liberate to Stimulate Index In recent years, Congress has faced mounting public pressure to “do something” about the rapidly rising prices of…
Washington Times
The FDA Needs Strong Medicine
Christmas came a couple of weeks late to the business sectors regulated by the Food and Drug Administration. The greatest threat to the success of…
Study
Improve Food Safety and Quality though Greater Information, Consumer Choice, and Legal Accountability
Full Document Available in PDF Few…
Washington Times
Food Safety: Why Is the Food Safety Bill So Controversial?
Washington Times
Food safety bill update (and welcome readers)
Washington Times
More FDA Authority Won’t Improve Food Safety
In its rush to enact sweeping new food safety legislation during the lame-duck session, Congress hit a procedural roadblock that may put the bill off…
Washington Times
The Environmental Impact Subterfuge
Action needs to be taken to prevent anti-biotech activists from co-opting environmental law to derail the planting of transgenic crops that have already received regulatory…
Study
International Fisheries
Full Document Available in PDF The history of fisheries management in the United States largely…
Washington Times
Does FDA’s Caffeinated Alcoholic Beverage Ban go too Far?
Washington Times
Greg Conko on “Frankenfish”
Competitive Enterprise Institute Senior Fellow Gregory Conko discusses the benefits and safety of genetically engineered foods. Humans have altered the genetic material of their food…
MPR News
Little Change to Agriculture Policy, Even as Peterson Loses Chair
MPR News
Angela Logomasini On The Risk of BPA
CEI Director of Risk and Environmental Policy Angela Logomasini discusses the risks and…
MPR News
High Cost Is Not Worst Thing About Obamacare (Letter to the Editor)
The Examiner was right to criticize Obamacare for being even more costly than many of its opponents expected, but the worst things about it…
MPR News
Upstream Battle for Genetically Engineered Salmon
Over the last two decades, the use of modern genetic engineering technology to produce pharmaceuticals and new crop plants has given rise to prodigious scientific,…
MPR News
Don’t Blame BPA on Lobster Decline
If you trust the headlines, you might think that the biggest challenge facing the lobster industry in New York and New England is pollution —…
Comment
CEI Comments regarding FDA’s Draft Guidance on the Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals
Executive Summary The Competitive Enterprise Institute respectfully submits these comments on the agency’s Draft Guidance on The Judicious Use of Medically Important Antimicrobial…
News Release
FDA Warned Against Hazards of Curtailing Antibiotic Use in Livestock
Washington, D.C., August 30, 2010 – The Competitive Enterprise Institute submitted comments today on an FDA proposal to limit the use of certain antibiotics in…
MPR News
Lobsters Should Fear Mother Nature More than Plastics
If you trust the headlines, you might think that the biggest challenge facing the lobster industry in New York and New England is pollution —…
MPR News
Greg Conko on Salmonella and Eggs
Competitive Enterprise Institute Senior Fellow Gregory Conko discusses the concern over salmonella and eggs. He explains why people do not need to panic.
MPR News
Seeking Food Safety, Getting Human Harm
Congress is set to consider a food-safety bill when it returns from the August recess. But the bill has so far stalled because of…